+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia



Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia



Blood 97(12): 3998-3999




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010723395

Download citation: RISBibTeXText

PMID: 11405211


Related references

Multiorgan failure during a sickle cell crisis in sickle/beta-thalassemia. American Journal of Kidney Diseases 42(2): E6-E8, 2003

Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 97(10): 3313-3314, 2001

The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β thal ), correlate with markers of hemolysis, iron burden, coagulation, endothelial dysfunction and pulmonary hypertension. Blood Cells, Molecules and Diseases 77: 137-141, 2019

Fatal splenic sequestration crisis with multiorgan failure in an adult woman with sickle cell-beta+ thalassemia. American Journal of the Medical Sciences 329(3): 141-143, 2005

Prevalence of factor V Leiden mutation in Greek patients with homozygous Sickle Cell Anemia or double heterozygous Sickle Cell/Thalassemia. American Journal of Human Genetics 65(4): A204, 1999

Acute Multiorgan failure in a patient with sickle cell/beta+ thalassemia. Blood 102(11): 20b, November 16, 2003

Types of Sickle Cell- Thalassemic Diseases. A. Sickle Cell-Beta Thalassemia. B. Sickle Cell-Alpha Thalassemia. Study of 6 Cases in 5 Families. Turk Tip Cemiyeti Mecmuasi 29: 313-320, 1963

Granulocyte colony-stimulating factor in sickle cell disease. CytoTherapy 11(8): 1108, 2010

Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease. Biology of Blood and Marrow Transplantation 14(6): 719-723, 2008

Intriguing prevalence of benin type sickle cell gene on atypical haplotypes in sickle cell beta thalassemia but not in sickle cell anemia in sicily italy. Bank, A (Ed ) Annals Of The New York Academy Of Sciences, Vol 612 Sixth Cooley's Anemia Symposium; New York, New York, Usa, March 13-15, Xiii+590p New York Academy Of Sciences: New York, New York, Usa Illus Maps 502-503, 1990

Frequency distribution of sickle cell anemia, sickle cell trait and sickle/beta-thalassemia among anemic patients in Saudi Arabia. Journal of Natural Science, Biology, and Medicine 6(Suppl 1): S85-S88, 2015

A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Biology of Blood and Marrow Transplantation 10(12): 848-857, 2004

Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?. CytoTherapy 11(4): 464-471, 2009

Acute sickle hepatic crisis after liver transplantation in a patient with sickle beta-thalassemia. Transplantation 90(4): 463-464, 2010

Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Pediatric Hematology and Oncology 16(3): 221-232, 1999